Evolution of the Average Target: Genpact Limited

Evolution of the Target Price: Genpact Limited

Changes in Analyst Recommendations: Genpact Limited

f6.gXoWVybOwGyipa6cZRQX_1kUclvIBEzuvTB1mOd6o-w.0hNxJ3-UmDmPy5zqCyJ_jHRZPWqJM3uD_n0H4tYDl9S0GG4ZEIqCA8rmwQ~79c1429f9ac79d7f9f27c4e2d601a0af
07/08 Analyst recommendations: Micron Technology, Lockheed Martin, Airbnb, Johnson Controls International, The Allstate Corporation… Zonebourse
11/05 Mizuho Securities Adjusts Genpact Price Target to $39 From $49, Maintains Neutral Rating MT
12/12 Susquehanna Initiates Genpact With Neutral Rating, $50 Price Target MT
08/25/08 Genpact Q2 revenue, adjusted profit beats estimates RE
27/25/27 TD Cowen Raises Price Target on Genpact to $55 From $53, Maintains Buy Rating MT
10/25/10 Analyst recommendations: Drax, AstraZeneca, HSBC, Broadcom, Tesla... Zonebourse
10/25/10 Analyst recommendations: Aspen, Amazon, Mattel, Broadcom, Tesla… Zonebourse
07/25/07 Deutsche Bank Adjusts Genpact Price Target to $55 From $48, Maintains Hold Rating MT
07/25/07 TD Cowen Upgrades Genpact to Buy From Hold, Adjusts Price Target to $60 From $45 MT
21/25/21 Jefferies Upgrades Genpact to Buy From Hold, Adjusts Price Target to $55 From $44 MT
21/25/21 Analyst recommendations: Apple, On Holding, Amazon, Palo Alto Networks, Tesla... Zonebourse
11/24/11 Deutsche Bank Adjusts Genpact Price Target to $48 From $37, Maintains Hold Rating MT
11/24/11 Analyst recommendations: Moderna, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Arista Networks... Zonebourse
17/24/17 JPMorgan Upgrades Genpact to Neutral From Underweight, Price Target is $40 MT
17/24/17 Analyst recommendations: American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly... Zonebourse
30/24/30 Mizuho Securities Initiates Genpact With Neutral Rating, Price Target is $40 MT
17/24/17 Citigroup Adjusts Price Target on Genpact to $36 From $35, Maintains Neutral Rating MT
15/23/15 Baird Downgrades Genpact to Neutral From Outperform, Price Target is $38 MT
13/23/13 Wedbush Lowers Genpact's PT to $35 From $45 After Weaker-Than-Expected Q3 Results, Resets Full-Year 2023 Guidance; Keeps Neutral Rating MT
22/23/22 JPMorgan Downgrades Genpact to Underweight From Neutral, Price Target is $40 MT
11/23/11 Needham Adjusts Genpact Price Target to $50 From $56, Maintains Buy Rating MT
10/23/10 Deutsche Bank Adjusts Genpact Price Target to $37 From $48, Maintains Hold Rating MT
10/23/10 BMO Capital Adjusts Price Target on Genpact to $41 From $46, Maintains Market Perform Rating MT
18/23/18 Citigroup Downgrades Genpact to Neutral From Buy, Adjusts Price Target to $42 From $46 MT
11/23/11 JPMorgan Cuts Genpact's Price Target to $46 From $53, Neutral Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+13.43%
+11.73%
+17.84%
+21.93%
+4.61%
+29.07%
+13.66%
+14.76%
+29.54%
Average +17.40%
Weighted average by Cap. +14.80%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
33.52USD
Average target price
42.18USD
Spread / Average Target
+25.84%
High Price Target
58.00USD
Spread / Highest target
+73.03%
Low Price Target
31.00USD
Spread / Lowest Target
-7.52%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. G Stock
  4. 35G Stock
  5. Consensus Genpact Limited